Brief: Neovacs to present clinical development update on ifnalpha kinoid in dermatomyosis
04/05/2017 07:01
May 4 (Reuters) - Neovacs Sa ALNEV.PA :
* Reg-Neovacs to present clinical development update on
ifnalpha kinoid in dermatomyosis
* Neovacs' Phase IIA clinical study in dermatomyositis is
currently ongoing
Source text for Eikon: ID:nGNE3Lqzsj
Further company coverage: ALNEV.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants